V
Veloxis Pharmaceuticals
Biotech & Life Sciences · Cary, United States · Founded 2002 · IPO 2006 Unicorn
Global footprint
Where Veloxis Pharmaceuticals has talent and traffic
team presence
across markets
Patent intelligence
$16M patent portfolio · 10 active families
Where Veloxis Pharmaceuticals concentrates vs peers
Each axis is a top-10 topic across Veloxis Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Veloxis Pharmaceuticals
An AI-synthesized read of the highest-engagement posts about Veloxis Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Veloxis Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.